Department Of Public Health 11
501. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
502. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
503. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
504. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
505. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
506. Global Neurosurgical Challenges: A Focus on Central Asia
507. The Evolving Role of Palliative Care in Older People with Glioblastoma
508. Fifty Years of Retracted Medical Publications From 1975 to 2024: A Comprehensive Analysis of Trends, Reasons, and Countries Using the Retraction Watch Database
509. Measuring Main Public Health Indicators of the Republic of Kazakhstan
510. The Re-emergence of Diphtheria Amidst Multiple Outbreaks in Nigeria
511. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
512. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
513. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
514. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
515. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
516. Phytochemical Profile and Biological Activity of the Ethanol Extracts from the Aerial Parts of Adonis tianschanica (Adolf.) Lipsch. Growing in Kazakhstan
517. Evaluating the waist circumference and waist–to–height ratio as most reliable indicators to determine abdominal obesity among adolescents: Findings from a cross-sectional study in Kazakhstan
518. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
519. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
520. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
521. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
522. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
523. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
524. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
525. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
526. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
527. Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey data
528. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
529. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
530. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
531. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
532. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
533. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
534. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
535. Preloaded combination nicotine replacement therapy for smoking cessation in Kazakhstan: A randomized controlled trial study protocol
536. The role of zygotic genome activation in genetic−related reproductive medicine: Technological perspective, religious and bioethical concerns, challenges and benefits
537. Correction to: Intranasal Oxytocin for Patients With Autism Spectrum Disorder: A Comprehensive Meta-Analysis of Preclinical and Clinical Studies (Review Journal of Autism and Developmental Disorders, (2026), 13, 1, (227-247), 10.1007/s40489-024-00428-3)
538. Correction to: Intranasal Oxytocin for Patients With Autism Spectrum Disorder: A Comprehensive Meta-Analysis of Preclinical and Clinical Studies (Review Journal of Autism and Developmental Disorders, (2026), 13, 1, (227-247), 10.1007/s40489-024-00428-3)
539. Intranasal Oxytocin for Patients With Autism Spectrum Disorder: A Comprehensive Meta-Analysis of Preclinical and Clinical Studies
540. Intranasal Oxytocin for Patients With Autism Spectrum Disorder: A Comprehensive Meta-Analysis of Preclinical and Clinical Studies
541. Strategies to Strengthen Iraqs Primary Healthcare System: A Systematic Literature Review With Special Focus on Society 5.0
542. Strategies to Strengthen Iraqs Primary Healthcare System: A Systematic Literature Review With Special Focus on Society 5.0
543. Strategies to Strengthen Iraqs Primary Healthcare System: A Systematic Literature Review With Special Focus on Society 5.0
544. The Effect of Psychological Rehabilitation on Depression, Anxiety, and Stress of Hearing-Impaired Children using Dohsa-hou Method
545. The Effect of Psychological Rehabilitation on Depression, Anxiety, and Stress of Hearing-Impaired Children using Dohsa-hou Method
546. The Impact of Human Cystic Echinococcosis in the Central Asian Region, 1990-2019
547. Under-Detection of Depressive Symptoms in Older Ambulatory Patients with Post-COVID Syndrome
548. Prevalence of Sexualized Substance Use and Chemsex in the General Population and Among Women: A Systematic Review and Meta-Analysis of Cross-Sectional Studies
549. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
550. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
1 9 10 11 12 13 15